These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 34212530)

  • 1. Outcomes of patients with schizophrenia who discontinued long-acting injectable antipsychotic therapy due to adverse events: A chart review.
    Kishi T; Sakuma K; Okuya M; Hatano M; Iwata N
    Neuropsychopharmacol Rep; 2021 Sep; 41(3):422-425. PubMed ID: 34212530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment Patterns, Health Care Resource Utilization, and Spending in Medicaid Beneficiaries Initiating Second-generation Long-acting Injectable Agents Versus Oral Atypical Antipsychotics.
    Pilon D; Tandon N; Lafeuille MH; Kamstra R; Emond B; Lefebvre P; Joshi K
    Clin Ther; 2017 Oct; 39(10):1972-1985.e2. PubMed ID: 28919292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-Acting Injectable Second-Generation Antipsychotics vs Placebo and Their Oral Formulations in Acute Schizophrenia: A Systematic Review and Meta-Analysis of Randomized-Controlled-Trials.
    Wang D; Schneider-Thoma J; Siafis S; Burschinski A; Dong S; Wu H; Zhu Y; Davis JM; Priller J; Leucht S
    Schizophr Bull; 2024 Jan; 50(1):132-144. PubMed ID: 37350486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second-generation long-acting injections anti-psychotics improve executive functions in patients with schizophrenia: a 12-month real-world study.
    Magliocco F; de Filippis R; Aloi M; Staltari FA; Gaetano R; Segura-Garcia C; De Fazio P
    Int J Psychiatry Clin Pract; 2020 Jun; 24(2):201-207. PubMed ID: 32134336
    [No Abstract]   [Full Text] [Related]  

  • 5. Cost Effectiveness of Paliperidone Long-Acting Injectable Versus Other Antipsychotics for the Maintenance Treatment of Schizophrenia in France.
    Druais S; Doutriaux A; Cognet M; Godet A; Lançon C; Levy P; Samalin L; Guillon P
    Pharmacoeconomics; 2016 Apr; 34(4):363-91. PubMed ID: 26883132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effectiveness of long-acting injectable antipsychotics in patients with schizophrenia in Japan.
    Okada Y; Inada K; Akazawa M
    Schizophr Res; 2023 Feb; 252():300-308. PubMed ID: 36706475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical evolution of patients treated with aripiprazole long-acting injectable: a preliminary, prospective, observational study.
    García Álvarez JC; González Sánchez L; García Resa E; Bonete Llácer JM; Román Rodríguez A; Pecino Esquerdo B; Pérez Martínez E
    Int J Psychiatry Clin Pract; 2020 Mar; 24(1):10-17. PubMed ID: 31933402
    [No Abstract]   [Full Text] [Related]  

  • 8. Healthcare resource utilization of second-generation long-acting injectable antipsychotics in schizophrenia: risperidone versus paliperidone palmitate.
    Joshi K; Pan X; Wang R; Yang E; Benson C
    Curr Med Res Opin; 2016 Nov; 32(11):1873-1881. PubMed ID: 27479694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Weight gain and metabolic screening in young people with early psychosis on long acting injectable antipsychotic medication (aripiprazole vs paliperidone).
    Shymko G; Grace T; Jolly N; Dobson L; Hacking D; Parmar A; Kapi P; Waters F
    Early Interv Psychiatry; 2021 Aug; 15(4):787-793. PubMed ID: 32715655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment discontinuation of long-acting injectables or oral atypical antipsychotics among Medicaid recipients with schizophrenia.
    Song X; El Khoury AC; Brouillette M; Smith D; Joshi K
    J Med Econ; 2019 Nov; 22(11):1105-1112. PubMed ID: 31062998
    [No Abstract]   [Full Text] [Related]  

  • 11. Tardive Dyskinesia and Long-Acting Injectable Antipsychotics: Analyses Based on a Spontaneous Reporting System Database in Japan.
    Misawa F; Fujii Y; Takeuchi H
    J Clin Psychiatry; 2022 Aug; 83(5):. PubMed ID: 35921512
    [No Abstract]   [Full Text] [Related]  

  • 12. A comparison of recurrence rates after discontinuation of second-generation antipsychotic long-acting injectable versus corresponding oral antipsychotic in the maintenance treatment of bipolar disorder: A systematic review.
    Kishi T; Citrome L; Sakuma K; Iwata N
    Psychiatry Res; 2024 Mar; 333():115761. PubMed ID: 38301289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperprolactinemia in psychotic patients treated in monotherapy with long-acting injectable antipsychotics.
    Bonete Llácer JM; Martínez Hortelano A; Richart Albelda B
    Int J Psychiatry Clin Pract; 2019 Sep; 23(3):189-193. PubMed ID: 30848967
    [No Abstract]   [Full Text] [Related]  

  • 14. Factors Associated with the Initiation of Long-Acting Injectable Paliperidone Palmitate Versus Aripiprazole Among Medicaid Patients with Schizophrenia: An Observational Study.
    Cai Q; Patel C; Kim E; Connolly N; Tunceli O; El Khoury AC
    Adv Ther; 2019 Apr; 36(4):858-869. PubMed ID: 30848442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse effects associated with second-generation antipsychotic long-acting injection treatment: a comprehensive systematic review.
    Gentile S
    Pharmacotherapy; 2013 Oct; 33(10):1087-106. PubMed ID: 23776129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Switching from oral atypical antipsychotic monotherapy to paliperidone palmitate once-monthly in non-acute patients with schizophrenia: A prospective, open-label, interventional study.
    Schreiner A; Caspi A; Bergmans P; Cherubin P; Keim S; Lara E; Pinchuk I; Schuepbach D; Suleman S; Hargarter L
    Psychopharmacology (Berl); 2017 Jan; 234(1):3-13. PubMed ID: 27815602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study of paliperidone palmitate and risperidone long-acting injectable therapy in schizophrenia.
    Li H; Rui Q; Ning X; Xu H; Gu N
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):1002-8. PubMed ID: 21315787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Acting Injectable Paliperidone Palmitate: A Review of Efficacy and Safety.
    Morris MT; Tarpada SP
    Psychopharmacol Bull; 2017 May; 47(2):42-52. PubMed ID: 28626271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of initiating long-acting injectable antipsychotics on hospitalization in patients with bipolar I disorder.
    Yan T; Greene M; Chang E; Touya M; Broder MS
    J Comp Eff Res; 2018 Nov; 7(11):1083-1093. PubMed ID: 30129771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Acting Injectable Second-Generation Antipsychotics: An Update and Comparison Between Agents.
    Jann MW; Penzak SR
    CNS Drugs; 2018 Mar; 32(3):241-257. PubMed ID: 29569082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.